This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Series A brings $1.3mm to Euclises Pharmaceuticals; $700k added
07 Apr 2015
Euclises Pharmaceuticals Inc. (oncology) raised $1.3mm through its Series A round led by Cultivation Capital. Life sciences accelerator BioGenerator also participated, along with Missouri Technology Corp., ABC Laboratories, the St. Louis Port Authority’s Helix Fund, and seed investors the St. Louis Arch Angels. BioGenerator and St. Louis Arch Angels join the board.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?